Literature DB >> 23648429

Arterial wall elasticity measured using the phased tracking method and atherosclerotic risk factors in patients with type 2 diabetes.

Michiaki Miyamoto1, Kazuhiko Kotani, Kenta Okada, Akihiko Ando, Hideyuki Hasegawa, Hiroshi Kanai, Shun Ishibashi, Toshiyuki Yamada, Nobuyuki Taniguchi.   

Abstract

AIM: The aim of this study was to investigate the relationship between atherosclerotic manifestations and brachial and radial arterial wall elasticity (AWE) measured using the phased tracking method in patients with type 2 diabetes mellitus (T2DM).
METHODS: This study included T2DM patients (n= 220, mean age 59 years) without a history of stroke or coronary artery disease. The brachial AWE, radial AWE, carotid mean intima-media thickness (IMT), max-IMT and flow-mediated vasodilation (FMD) were measured. The patients were classified according to the number of atherosclerotic risk factors, including obesity, dyslipidemia and hypertension. Group 1 included T2DM patients only, group 2 included patients with two risk factors, group 3 included patients with three risk factors and group 4 included patients with four risk factors. The patients were also divided into two groups according to microangiopathic complications, including retinopathy and nephropathy. The between-group differences were analyzed.
RESULTS: The brachial AWE (548, 697, 755 and 771 kPa for groups 1, 2, 3 and 4, respectively) and radial AWE (532, 637, 717 and 782 kPa for groups 1, 2, 3 and 4, respectively) significantly increased in association with an increasing number of risk factors. The brachial AWE and radial AWE were significantly higher in the patients with microangiopathic complications than in those without microangiopathic complications (brachial AWE 797 and 694 kPa and radial AWE 780 and 660 kPa, respectively). Receiver operating characteristic curve analyses revealed that, for brachial AWE and radial AWE, the area under the curve was equal to the max-IMT and higher than the mean-IMT and FMD.
CONCLUSIONS: Upper limb AWE measurement can reflect the degree of atherosclerosis risk overload and may be useful for evaluating vascular complications in T2DM patients.

Entities:  

Mesh:

Year:  2013        PMID: 23648429     DOI: 10.5551/jat.16220

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  5 in total

1.  Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity.

Authors:  Stefanie R van Mil; L Ulas Biter; Gert-Jan M van de Geijn; Erwin Birnie; Martin Dunkelgrun; Jan N M IJzermans; Noelle van der Meulen; Guido H H Mannaerts; Manuel Castro Cabezas
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

Review 2.  A Review on Atherosclerotic Biology, Wall Stiffness, Physics of Elasticity, and Its Ultrasound-Based Measurement.

Authors:  Anoop K Patel; Harman S Suri; Jaskaran Singh; Dinesh Kumar; Shoaib Shafique; Andrew Nicolaides; Sanjay K Jain; Luca Saba; Ajay Gupta; John R Laird; Argiris Giannopoulos; Jasjit S Suri
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

3.  Noninvasive early detection of anthracycline-induced cardiotoxicity in patients with hematologic malignancies using the phased tracking method.

Authors:  Yoshiko Saito; Ikuko Susukida; Yoshiro Uzuka; Hiroshi Kanai
Journal:  Cancer Med       Date:  2016-08-03       Impact factor: 4.452

4.  Proof-of-Concept Study for an Enhanced Surrogate Marker of Endothelial Function in Diabetes.

Authors:  R Dalan; S Goh; Sun Bing; A Seneviratna; C T Phua
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

Review 5.  Does Aerobic plus Machine-Assisted Resistance Training Improve Vascular Function in Type 2 Diabetes? A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis.

Authors:  Xianshan Guo; Shizhe Guo; Hongmei Zhang; Zhen Li
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.